Skip to main content
. 2011 Dec;92(6):400–412. doi: 10.1111/j.1365-2613.2011.00789.x

Table 3.

Density of immunoreactivity to specific neurotransmitters and cell populations (A) and counts of immunohistochemically defined neuronal cell bodies (B) in ileal and mid-colonic myenteric plexus

Ileum Mid-colon


Control Diabetic Control Diabetic
(A) % positivity against
 NSE 19.5 ± 1.6 (8) 20.5 ± 1.5 (8) 42.3 ± 2.1 (8) 35.5 ± 1.9 (7)*
 VIP 0.8 ± 0.1 (3) 1.3 ± 0.1 (4)** 7.2 ± 0.4 (4) 11.8 ± 1.8 (4)*
 SP 1.5 ± 0.3 (4) 2.5 ± 0.2 (4)* 4.3 ± 0.8 (5) 7.6 ± 0.4 (4)*
 GFAP 7.5 ± 0.6 (4) 8.6 ± 0.8 (4) 11.9 ± 1.9 (4) 12.1 ± 0.4 (4)
 c-kit 43.7 ± 1.9 (4) 39.9 ± 3.7 (3) 42.4 ± 1.9 (4) 39.4 ± 1.5 (4)
(B) Neuronal counts
 HuD+ neurons/0.17 mm2 61.5 ± 4.6 (7) 51.6 ± 4.4 (6)* 88.3 ± 4.8 (7) 75.0 ± 3.3 (7)*
 % HuD+ neurons stained for
  nNOS 25.8 ± 3.1 (3) 31.8 ± 4.3 (3) 39.6 ± 4.0 (4) 41.6 ± 3.8 (4)
  ChAT 79.0 ± 5.1 (3) 76.3 ± 2.5 (3) 71.4 ± 8.2 (4) 76.4 ± 3.9 (4)
  Cleaved caspase-3 1.4 ± 1.0 (3) 4.5 ± 2.0 (4) 2.4 ± 1.2 (3) 2.8 ± 1.4 (3)
  Bcl-2 20.6 ± 2.3 (3) 17.3 ± 2.8 (3) 15.0 ± 2.4 (3) 19.0 ± 2.4 (3)
No. +neurons/15 ganglia
  VIP 3.5 ± 0.9 (4) 9.0 ± 1.1 (4)** 23.4 ± 3.5 (5) 14.5 ± 2.4 (4)
  SP 11.3 ± 1.5 (4) 8.8 ± 0.7 (4) 8.9 ± 1.6 (5) 6.8 ± 1.2 (4)

GFAP, glial fibrillary acidic protein; NSE, neuron-specific enolase.

Figures represent mean ± SEM. The numbers of animals used are given in parentheses. Data in (A) are expressed as mean percent immunofluorescent area per scanned field. NSE staining was evaluated at 10× magnification (0.75 mm2/field). Samples immunostained with VIP, SP, GFAP or c-kit were scanned at 20× magnification (0.17 mm2/field). Counts in (B) are expressed as absolute numbers per 0.17 mm2 field, relative to total HuD-positive neurons or as absolute numbers in 15 ganglia. Only those neurons moderately to strongly immunoreactive for any given marker were quantified. Comparisons between groups were performed using the Student's t-test.

*

P<0.05 vs. control mice

**

P<0.01 vs. control mice.